Animal study · rats
BPC-157 reduced leg muscle damage after ischemia-reperfusion in rats
Checked against the paper Animal studyPublished by PepVault
The takeaway
This small rat study points to BPC-157 limiting muscle damage when blood flow is cut off and restored, but it is an animal result, not one in people.
- Kind
- Animal study
- Studied in
- Rats
- Published
- 2026
- Journal
- Sci Rep
What they tested
The team tested whether BPC-157 protects leg muscle in rats from ischemia-reperfusion injury, the damage that follows when blood flow is cut off and then restored.
How the study was done
A randomized study in male Wistar rats split into four groups of 6: sham surgery, BPC-157 alone, injury alone, and injury plus BPC-157. The main artery in the belly was clamped for 45 min, then blood flow was restored for 2 h, and the BPC-157 groups got one 20 µg/kg dose into the abdominal cavity at the 45th minute of clamping.

What they found
In rats, the injury raised markers of oxidative stress (MDA, TOS) and cell death signals (p53, Bax, Casp3), lowered SOD, TAS and VEGF, and worsened tissue damage scores. Injured rats given BPC-157 had lower MDA and TOS, recovered SOD and TAS, and lower p53, Bax and Casp3 than injured rats without it. They also showed less IL-6, an inflammation signal, less Caspase-3 staining, higher Bcl-2, and partial recovery of VEGF. Under the microscope, their muscle looked better organized and had less collagen buildup than in injured rats without BPC-157.
What it doesn’t show
These results come from a rat model of clamped blood flow, and people with artery disease may respond differently. With just 6 rats per group, one dose given during the clamping, and tissue checked only 2 h after blood flow returned, it can't show the best dose or whether the benefit lasts.
The paper
Yıldırım et al. Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury. Sci Rep. 2026.
The compound
More studies on BPC-157
- BPC-157: 10 of 12 women reported full interstitial cystitis reliefClinical trial · people · 2024
- BPC-157: 14 of 16 reported knee pain relief in a chart reviewObservational study · people · 2021
- BPC-157: non-significant tendon gains in rats; TB-500 did betterAnimal study · rats · 2026
- BPC-157 closed duodenocolic fistulas in ratsAnimal study · rats · 2024
- BPC-157 limited isoprenaline-induced heart attack damage in ratsAnimal study · rats · 2022
- BPC-157 reduced radiation liver injury in mice and rat liver cellsAnimal study · mice · 2022
- Every study on BPC-157
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.